NCT07341191
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07341191
Title Sonrotoclax Plus Zanubrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma Planned for Standard of Care CAR-T Cell Therapy
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Canadian Cancer Trials Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries CAN

Facility Status City State Zip Country Details
Arthur J.E. Child Comprehensive Cancer Centre RECRUITING Calgary Alberta T2N 5G2 Canada Details
Cross Cancer Institute RECRUITING Edmonton Alberta T6G 1Z2 Canada Details
BCCA - Vancouver RECRUITING Vancouver British Columbia V5Z 4E6 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences RECRUITING Hamilton Ontario L8V 5C2 Canada Details
University Health Network RECRUITING Toronto Ontario M5G 2M9 Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field